Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > more insider buying ...

<< Previous

Bullboard Posts

Next >>

Comment by Snowballgrowthon Jan 16, 2021 8:07am

146 Views

Post# 32312810

RE:RE:RE:more insider buying ...

MrMugsy wrote:

Doccole wrote: I've been watching this. There has been a considerable amount of insider buying. What catalyst could be on the verge? There is a ton of money in the bank!

Doccole ... Goodman plays to win but he plays by his own rules.
Slow and steady - buying when he likes what's available - for the right price.
Almost impossible to guess how./when it plays out.

There will be small acquisitions added to various moves in building out rest-of-world.

One day, the stock just starts to climb and doesn't look back ... but ... we're not there yet.
It take time for the market to understand and like a drug marketing company.

See the following video and understand that it will likely look similar - paying attention to the graph at 8 minutes and 30 seconds. Notice how slow it runs for many initial years.

Hope this helps.

https://www.youtube.com/watch?v=YCps-WZB7_U

"It take time for the market to understand and like a drug marketing company."

I don't think the issue is about the market. The market rewards good execution, growth and the numbers.

<< Previous

Bullboard Posts

Next >>

This junior mining stock offers billions in market exposure